Marshall Wace North America’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $236M | Sell |
5,446,332
-413,523
| -7% | -$17.9M | 1.01% | 11 |
|
|
2021
Q2 | $251M | Buy |
5,859,855
+1,089,462
| +23% | +$46.6M | 1.04% | 11 |
|
|
2021
Q1 | $184M | Buy |
4,770,393
+180,286
| +4% | +$6.97M | 0.76% | 17 |
|
|
2020
Q4 | $165M | Buy |
4,590,107
+693,756
| +18% | +$24.9M | 0.74% | 18 |
|
|
2020
Q3 | $149M | Sell |
3,896,351
-1,357,198
| -26% | -$51.9M | 0.95% | 18 |
|
|
2020
Q2 | $184M | Buy |
5,253,549
+166,825
| +3% | +$5.86M | 1.22% | 9 |
|
|
2020
Q1 | $166M | Sell |
5,086,724
-2,303,173
| -31% | -$75.2M | 1.26% | 11 |
|
|
2019
Q4 | $334M | Sell |
7,389,897
-1,263,791
| -15% | -$57.1M | 1.61% | 3 |
|
|
2019
Q3 | $352M | Buy |
8,653,688
+218,273
| +3% | +$8.88M | 2% | 4 |
|
|
2019
Q2 | $363M | Sell |
8,435,415
-567,255
| -6% | -$24.4M | 2.25% | 1 |
|
|
2019
Q1 | $346M | Buy |
9,002,670
+2,494,598
| +38% | +$95.7M | 2.44% | 2 |
|
|
2018
Q4 | $230M | Sell |
6,508,072
-825,324
| -11% | -$29.2M | 2.23% | 5 |
|
|
2018
Q3 | $282M | Sell |
7,333,396
-1,615,233
| -18% | -$62.2M | 1.94% | 4 |
|
|
2018
Q2 | $293M | Sell |
8,948,629
-2,567,644
| -22% | -$84M | 1.65% | 2 |
|
|
2018
Q1 | $315M | Buy |
11,516,273
+1,205,496
| +12% | +$32.9M | 1.58% | 3 |
|
|
2017
Q4 | $256M | Buy |
10,310,777
+7,929,843
| +333% | +$197M | 1.41% | 5 |
|
|
2017
Q3 | $69M | Buy |
2,380,934
+197,751
| +9% | +$5.73M | 0.44% | 39 |
|
|
2017
Q2 | $61.1M | Sell |
2,183,183
-3,811,174
| -64% | -$107M | 0.45% | 49 |
|
|
2017
Q1 | $150M | Buy |
+5,994,357
| New | +$150M | 1.18% | 6 |
|